AUTOTAC Trademark

Trademark Overview

On Tuesday, September 24, 2019, a trademark application was filed for AUTOTAC with the United States Patent and Trademark Office. The USPTO has given the AUTOTAC trademark a serial number of 88628744. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 12, 2023. This trademark is owned by Frontier Medicines Corporation. The AUTOTAC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals composed of protein-, protein aggregate-, organelle- and pathogen-degrading compounds for therapeutic use in treating of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, Amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, and infectious diseases in humans
autotac

General Information

Serial Number88628744
Word MarkAUTOTAC
Filing DateTuesday, September 24, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 12, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 17, 2020

Trademark Statements

Goods and ServicesPharmaceuticals composed of protein-, protein aggregate-, organelle- and pathogen-degrading compounds for therapeutic use in treating of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, Amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, and infectious diseases in humans

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFrontier Medicines Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameFrontier Medicines Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, June 12, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 12, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, November 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 17, 2022SOU EXTENSION 5 GRANTED
Tuesday, November 8, 2022SOU EXTENSION 5 FILED
Thursday, November 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 8, 2022SOU TEAS EXTENSION RECEIVED
Saturday, February 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 3, 2022SOU EXTENSION 4 GRANTED
Thursday, February 3, 2022SOU EXTENSION 4 FILED
Thursday, February 3, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, September 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 17, 2021SOU EXTENSION 3 GRANTED
Friday, September 17, 2021SOU EXTENSION 3 FILED
Friday, September 17, 2021SOU TEAS EXTENSION RECEIVED
Saturday, May 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 6, 2021SOU EXTENSION 2 GRANTED
Thursday, May 6, 2021SOU EXTENSION 2 FILED
Thursday, May 6, 2021SOU TEAS EXTENSION RECEIVED
Thursday, October 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 20, 2020SOU EXTENSION 1 GRANTED
Tuesday, October 20, 2020SOU EXTENSION 1 FILED
Tuesday, October 20, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, May 12, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 11, 2020ASSIGNED TO LIE
Friday, February 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 7, 2020EXAMINER'S AMENDMENT ENTERED
Friday, February 7, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 7, 2020EXAMINERS AMENDMENT E-MAILED
Friday, February 7, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 7, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2020NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2020NON-FINAL ACTION WRITTEN
Thursday, December 26, 2019ASSIGNED TO EXAMINER
Saturday, September 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 27, 2019NEW APPLICATION ENTERED

Related Keywords

autotac disease diseases protein amyotrophic lateral bowel hypertension autoimmune sclerosis inflammatory